Studies in young adults agreed that low HDL cholesterol levels and hypertriglyceridemia were associated with serum FABP1 levels, suggesting it as a possible circulating biomarker of adiposity and metabolic diseases associated with insulin resistance, involved in hepatic lipid binding and lipid metabolism (Shi et al., 2012). This evidence concerns the gene FABP1 and Other metabolic disease.